Skip to Main Content

Author Details

Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
2004
99
37
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37917186The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study.Clin Exp Metastasis2024
36849657Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.Nat Genet2023
37833300Brain proteomic atlas of alcohol use disorder in adult males.Transl Psychiatry2023
37639904Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.Gynecol Oncol2023
35326647Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer.Cancers (Basel)2022
35723500Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment.J Vis Exp2022
36528667Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.J Transl Med2022
36239936Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.JAMA Netw Open2022
36195845Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues.Clin Proteomics2022
34278265Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.iScience2021
33931688Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients.Sci Rep2021
35036865Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.iScience2021
32294438Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.Cell Rep2020
31808620Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.Cancer Med2020
33067419Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies.Nat Commun2020
31279844Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.Am J Obstet Gynecol2019
30110125CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.Int J Cancer2019
31242424Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome.Cell Rep2019
29205518Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome.Exp Dermatol2018
28654152Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.Cancer2017
28251557Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.Hum Cell2017
28502009Quantitative Mass Spectrometry by Isotope Dilution and Multiple Reaction Monitoring (MRM).Methods Mol Biol2017
29123096ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.Nat Commun2017
28638726Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.Oncoimmunology2017
27235625Human DNA polymerase ε is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19.DNA Repair (Amst)2016
25748058Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.J Proteome Res2015
26401960Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.J Proteome Res2015
25927284BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.Cell Cycle2015
25619993The assembly of miRNA-mRNA-protein regulatory networks using high-throughput expression data.Bioinformatics2015
25695723Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle.Biol Reprod2015
24178762Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes.Br J Cancer2014
25033841Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.Mol Cancer Res2014
25100294Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.Cancer2014
24692084Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas.Cancer2014
24727329Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.Clin Cancer Res2014
23063503Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.Hum Pathol2013
23880299The bc:caa3 supercomplexes from the Gram positive bacterium Bacillus subtilis respiratory chain: a megacomplex organization?Arch Biochem Biophys2013
23682076Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells.Cancer Prev Res (Phila)2013
23280476An integrated understanding of the physiological response to elevated extracellular phosphate.J Cell Physiol2013
22203240CLT1 targets angiogenic endothelium through CLIC1 and fibronectin.Angiogenesis2012
22993125The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.Acta Neuropathol2012
22700653The aerobic respiratory chain of Escherichia coli: from genes to supercomplexes.Microbiology (Reading)2012
22783543Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer.Front Oncol2012
22912665Mitochondrial respiration--an important therapeutic target in melanoma.PLoS One2012
22909323Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexes.J Proteome Res2012
22900918Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer.J Proteome Res2012
22077639Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard.J Proteome Res2012
20950718Serum proteomics signature of cystic fibrosis patients: a complementary 2-DE and LC-MS/MS approach.J Proteomics2011
21838287Identification of potential protein targets of isothiocyanates by proteomics.Chem Res Toxicol2011
21801426Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.AIDS Res Ther2011
  • 1 - 50 of 99

Recommended Authors

Max Planck Institute of Biochemistry
Career Start Year 2011
Number of shared co-authors 1
Margaret Cancer Center
Career Start Year 2009
Number of shared co-authors 3
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2006
Number of shared co-authors 0
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 2
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2005
Number of shared co-authors 1
Pacific Northwest National Laboratory
Career Start Year 2005
Number of shared co-authors 0
Yonsei University
Career Start Year 2005
Number of shared co-authors 2
Howard Hughes Medical Institute, University of California San Diego
Career Start Year 2003
Number of shared co-authors 1
Stanford University
Career Start Year 2003
Number of shared co-authors 1
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 0
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 2
Tel Aviv University
Career Start Year 2000
Number of shared co-authors 0
Pacific Northwest National Laboratory
Career Start Year 2000
Number of shared co-authors 1
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 1
Institute of Molecular and Cell Biology
Career Start Year 2000
Number of shared co-authors 1
Boston Children's Hospital, USA Harvard Medical School, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 1
Stanford University
Career Start Year 2000
Number of shared co-authors 3
Hospital for Sick Children
Career Start Year 1999
Number of shared co-authors 1
Pacific Northwest National Laboratory
Career Start Year 1998
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 1
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 3
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University
Career Start Year 1996
Number of shared co-authors 0
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Career Start Year 1996
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Max-Planck Institute of Biochemistry
Career Start Year 1989
Number of shared co-authors 4
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 1984
Number of shared co-authors 3
Macquarie University
Career Start Year 1984
Number of shared co-authors 4
Broad Institute of MIT and Harvard
Career Start Year 1980
Number of shared co-authors 4
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 8

Collaborators

Women's Health Integrated Research Center, Inova Health System
Co-authored papers 96
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 24
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers 13
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Co-authored papers 7
Uniformed Services University of the Health Sciences
Co-authored papers 5
University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
UPMC Hillman Cancer Center, University of Pittsburgh
Co-authored papers 4
Co-authored papers 3
Duke School of Medicine
Co-authored papers 3
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 3
Walter Reed National Military Medical Center
Co-authored papers 3
Co-authored papers 3
UPMC-Hillman Cancer Center, University of Pittsburgh
Co-authored papers 2
Co-authored papers 2
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Co-authored papers 2
Co-authored papers 2
Uniformed Services University of the Health Sciences
Co-authored papers 2
Co-authored papers 2
Howard Hughes Medical Institute, University of California at Davis
Co-authored papers 1
Amgen Inc.
Co-authored papers 1
Margaret Cancer Center
Co-authored papers 1
ETH Zurich
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Florida
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California
Co-authored papers 1
UPMC Hillman Cancer Center
Co-authored papers 1